Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FGF20: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
FGF20 is a protein involved in neurodegeneration research. Key relationships include: therapeutic target, implicated in. Associated with Als, Cancer, Carcinoma. Connected to 85 entities in the SciDEX knowledge graph.
| Gene Symbol | FGF20 |
| Full Name | Fibroblast Growth Factor 20 |
| Chromosome | 8p21.3 |
| Function | FGF20 is a member of the FGF family of growth factors, which are involved in various developmental and regenerative processes. |
| Primary Expression | the brain, particularly in the substantia nigra |
| Molecular Weight | 23 kDa |
| Pathways | PI3K, MAPK |
| UniProt ID | Q9NP95 |
| NCBI Gene ID | 56844 |
| Ensembl ID | ENSG00000078579 |
| OMIM | 605830 |
| GeneCards | FGF20 |
| Human Protein Atlas | FGF20 |
| Associated Diseases | neurodegeneration |
| KG Connections | 111 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
FGF20["FGF20"] -->|"therapeutic target"| Fibrosis["Fibrosis"]
FGF20["FGF20"] -->|"therapeutic target"| Hepatitis["Hepatitis"]
FGF20["FGF20"] -->|"therapeutic target"| Carcinoma["Carcinoma"]
FGF20["FGF20"] -->|"therapeutic target"| Cancer["Cancer"]
FGF20["FGF20"] -->|"therapeutic target"| Als["Als"]
FGF20["FGF20"] -->|"therapeutic target"| Inflammation["Inflammation"]
ALDH1A1["ALDH1A1"] -->|"therapeutic target"| FGF20["FGF20"]
MITF["MITF"] -->|"therapeutic target"| FGF20["FGF20"]
LEF1["LEF1"] -->|"therapeutic target"| FGF20["FGF20"]
CANCER["CANCER"] -->|"therapeutic target"| FGF20["FGF20"]
style FGF20 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Fibrosis | therapeutic_target | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Prostate Cancer | therapeutic_target | disease | 0.65 |
| Infection | therapeutic_target | disease | 0.65 |
| Hepatocellular Carcinoma | therapeutic_target | disease | 0.65 |
| Colorectal Cancer | therapeutic_target | disease | 0.65 |
| Liver Cancer | therapeutic_target | disease | 0.65 |
| Pulmonary Fibrosis | therapeutic_target | disease | 0.65 |
| Lung Cancer | therapeutic_target | disease | 0.65 |
| Pancreatic Cancer | therapeutic_target | disease | 0.65 |
| Gastric Cancer | therapeutic_target | disease | 0.65 |
| BRG1 | therapeutic_target | gene | 0.60 |
| NRCAM | therapeutic_target | gene | 0.60 |
| NOTCH2 | therapeutic_target | gene | 0.60 |
| EP300 | therapeutic_target | gene | 0.60 |
| CTNNB1 | therapeutic_target | gene | 0.60 |
| NEUROD1 | therapeutic_target | gene | 0.60 |
| MYC | therapeutic_target | gene | 0.60 |
| VEGFA | therapeutic_target | gene | 0.60 |
| ABCB1 | therapeutic_target | gene | 0.60 |
| FOXM1 | therapeutic_target | gene | 0.60 |
| LEF1 | therapeutic_target | gene | 0.60 |
| SMARCA4 | therapeutic_target | gene | 0.60 |
| TERT | therapeutic_target | gene | 0.60 |
| FZD7 | therapeutic_target | gene | 0.60 |
| JAG1 | therapeutic_target | gene | 0.60 |
| MITF | therapeutic_target | gene | 0.60 |
| GAIN | therapeutic_target | gene | 0.60 |
| AXIN2 | therapeutic_target | gene | 0.60 |
| CD44 | therapeutic_target | gene | 0.60 |
| ALDH1A1 | therapeutic_target | gene | 0.60 |
| FGF18 | therapeutic_target | gene | 0.60 |
| ATF3 | therapeutic_target | gene | 0.60 |
| IL10 | therapeutic_target | gene | 0.60 |
| DKK1 | therapeutic_target | gene | 0.60 |
| PPARD | therapeutic_target | gene | 0.60 |
| CLDN1 | therapeutic_target | gene | 0.60 |
| APC | therapeutic_target | gene | 0.60 |
| AXIN1 | therapeutic_target | gene | 0.60 |
| PTGS2 | therapeutic_target | gene | 0.60 |
| CREBBP | therapeutic_target | gene | 0.60 |
| FZD7 | targets | gene | 0.60 |
| IL10 | targets | gene | 0.60 |
| JAG1 | targets | gene | 0.60 |
| LEF1 | targets | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALDH1A1 | therapeutic_target | gene | 0.60 |
| MITF | therapeutic_target | gene | 0.60 |
| LEF1 | therapeutic_target | gene | 0.60 |
| ABCB1 | therapeutic_target | gene | 0.60 |
| CLDN1 | therapeutic_target | gene | 0.60 |
| JAG1 | therapeutic_target | gene | 0.60 |
| CTNNB1 | therapeutic_target | gene | 0.60 |
| AXIN1 | therapeutic_target | gene | 0.60 |
| EP300 | therapeutic_target | gene | 0.60 |
| BRG1 | therapeutic_target | gene | 0.60 |
| CD44 | therapeutic_target | gene | 0.60 |
| FGF18 | therapeutic_target | gene | 0.60 |
| SMARCA4 | therapeutic_target | gene | 0.60 |
| MYC | therapeutic_target | gene | 0.60 |
| NRCAM | therapeutic_target | gene | 0.60 |
| TERT | therapeutic_target | gene | 0.60 |
| NOTCH2 | therapeutic_target | gene | 0.60 |
| PPARD | therapeutic_target | gene | 0.60 |
| NEUROD1 | therapeutic_target | gene | 0.60 |
| APC | therapeutic_target | gene | 0.60 |
| CREBBP | therapeutic_target | gene | 0.60 |
| GAIN | therapeutic_target | gene | 0.60 |
| VEGFA | therapeutic_target | gene | 0.60 |
| IL10 | therapeutic_target | gene | 0.60 |
| FZD7 | therapeutic_target | gene | 0.60 |
| AXIN2 | therapeutic_target | gene | 0.60 |
| ABCB1 | targets | gene | 0.60 |
| ALDH1A1 | targets | gene | 0.60 |
| ATF3 | targets | gene | 0.60 |
| AXIN2 | targets | gene | 0.60 |
| CD44 | targets | gene | 0.60 |
| CLDN1 | targets | gene | 0.60 |
| DKK1 | targets | gene | 0.60 |
| FGF18 | targets | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| CDH1 | therapeutic_target | gene | 0.60 |
| INFLAMMATION | therapeutic_target | gene | 0.60 |
| BAMBI | therapeutic_target | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| BAMBI | targets | gene | 0.60 |
| CCND1 | targets | gene | 0.60 |
| CTLA4 | targets | gene | 0.60 |
| EOMES | targets | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||